2019
Lea I , Liu Y, Sheridan E, Motti D, Martini C, Fostel J, Auerbach S. Hallmark gene set annotation for NTP toxicogenomic studies. Presented at the 58th Annual Meeting of Society of Toxicology, Baltimore, MD, March 2019. Abstract #1743-P119.
View Abstract
Publication: Abstracts and Presentations
Martini C, Liu Y, Motti D, Johnson J, McCormick K, Lea I , Fostel F. Integrating assay datasets into Chemical Effects in Biological Systems (CEBS). Presented at the 58th Annual Meeting of Society of Toxicology, Baltimore, MD, March 2019. Abstract #1749-P125.
View Abstract
Publication: Abstracts and Presentations
2018
Kimzey AL , Piche M-S, Wood M , Weir AB, Lansita J . 2018. 11.19 – Immunophenotyping in drug development. In: Comprehensive Toxicology, 3rd Ed. Vol 11:399–427 .
View Abstract
Publication: Book Chapters
Tsaioun K, Dirven H, Beck Færden K, Wikoff D , Ram R, Kleinstreuer N, McCormack A, Wright R, Vist GE, Fitch S . 2018. Systematic reviews of the hepatotoxic effects of specified compounds/drugs as observed in humans and experimental animals (rats, mice, dogs and non-human primates). PROSPERO CRD42018112353 .
View Abstract
Publication: Manuscripts , Protocol Registrations
Borghoff SJ, Fitch S , Rager JE, Huggett D. 2018. A hypothesis-driven weight-of-evidence analysis to evaluate potential endocrine activity of perfluorohexanoic acid. Regul Toxicol Pharmacol 99:168–181.
View Abstract
Publication: Manuscripts
Grimm FA, Klaren WD , Li X, House JS, Chiu W, Lehmler HJ, Robertson LW, Rusyn I. Cardiotoxicity screening of polychlorinated biphenyls and their major metabolites. Society of Toxicology Annual Meeting, San Antonio, Tx (presenter), 2018.
View Abstract
Publication: Abstracts and Presentations
Klaren WD , Grimm FA, Shen H, Rusyn I. In vitro approaches to grouping of complex substances and UVCBs: A case study of olefin streams. Society of Toxicology Annual Meeting, San Antonio, Tx, 2018.
View Abstract
Publication: Abstracts and Presentations
Borghoff S , Wikoff D , Urban JD , Rager JE . A systematic approach to identify plausible mode-of-actions (MOA) for an increased incidence of lung tumors in mice with chronic exposure to 4-methylimidazole (4-MEI). Society of Toxicology Annual Meeting. March 11–15, 2018. San Antonio, TX.
View Abstract